Skip to main content

What are the Requirements in Europe for Closure Liners Intended to Package Pharmaceuticals?

Is European Pharmacopeia compliance required for closure liners which may be used for pharmaceuticals in the EU?

Are Soap Ingredients Required to be Listed on a Package?

What is the law regarding ingredient listing on bar soap packaging? If the ingredients are listed inside the packaging, do they also need to be...

What is the purpose of an 'e' in Skin Care Labeling and when should it be used?

In the skin care industry, an 'e' is sometimes used on a weight claim on a folding carton or container, such as 4.0 Fl. Oz. e 120 ml. What is the...

Do repackaged OTC vitamins/supplements have to be in childproof containers?

When repackaging OTC vitamins/supplements, do they have to be in a childproof container?

The U.S. Food and Drug Administration (FDA) has established a deadline after which all new drug applications (NDAs), abbreviated new drug applications (ANDAs), certain biologics license applications (BLAs), and certain investigational new drug applications (INDs) will need to be submitted electronically. Section 745A(a) of the Federal Food, Drug, and Cosmetic Act requires that certain drug and biologic submissions be submitted in electronic format within 24 or 36 months after FDA's issuance of final guidance on that topic.

Health Canada has increased Drug Master File (DMF) filing fees, effective as of April 1, 2015. The revised fee structure increases the cost of filing a new DMF to $424 (Canadian), the cost of filing a biannual update to $191 (Canadian), and the cost of filing a Letters of Access to $191 (Canadian).

The plastics industry and drug manufacturers have challenged India's proposed ban on the use of polyethylene terephthalate (PET) containers for primary drug packaging of liquid oral formulations for pediatric use, geriatric use, and for pregnant women and women of reproductive age.